GHK-Cu vs BPC-157: Anti-Aging vs Healing Peptides
Compare GHK-Cu (copper peptide for skin and anti-aging) vs BPC-157 (body protection compound for healing). Different uses, mechanisms, and when to use each.
| Dimension | ghk-cu | bpc-157 | Notes |
|---|---|---|---|
| Primary Use | Skin/anti-aging | Injury healing | GHK-Cu excels at skin rejuvenation and collagen synthesis. BPC-157 targets internal tissue repair. |
| Mechanism | Copper delivery + gene modulation | Angiogenesis + growth factor upregulation | Different pathways — GHK-Cu modulates 4,000+ genes. BPC-157 promotes blood vessel growth and tissue repair. |
| Administration | Topical, SubQ, or IV | SubQ or oral | GHK-Cu uniquely effective as topical application for skin. BPC-157 has oral bioavailability. |
| Research Level | Moderate | Moderate | Both have solid preclinical data. GHK-Cu has more human skin studies; BPC-157 more animal healing studies. |
| Side Effects | Very mild | Very mild | Both well-tolerated. GHK-Cu topical has essentially zero systemic side effects. |
| Cost | $25-60/vial | $30-60/vial | Similar pricing. GHK-Cu topical serums can be more expensive from cosmetic brands. |
Learn more about each peptide
GHK-Cu
GHK-Cu (copper peptide) is a naturally occurring tripeptide bound to copper that declines with age. It is one of the most well-researched peptides for skin regeneration, wound healing, and anti-aging, with over 60 years of published research.
BPC-157
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in human gastric juice. It has shown remarkable healing properties in preclinical studies across tendons, ligaments, muscle, gut, and nervous system tissue.
More comparisons
Weekly peptide research updates
New studies, GLP-1 news, protocol insights, and weight loss data — delivered every week. Free. No spam.
Reviewed by Fat Man in the Arena · Updated March 2026
Medical Disclaimer: This comparison is for informational purposes only. Individual responses vary. Always consult a qualified healthcare provider before starting any peptide protocol.